Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 4 4Phase 3 4Phase 1/2 3Phase 2/3 1Phase 1 1

Status

Completed 4

Sponsor Class

INDUSTRY 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 2

Conditions

Psoriasis 2Lymphoma, Follicular 2Pruritus 1Pneumonia 1Plaque, Amyloid 1Bronchiolitis Obliterans Syndrome 1Arthritis, Rheumatoid 1

Interventions

Cisplatin 187Carboplatin 182Paclitaxel 177Docetaxel 145Cyclophosphamide 129Dexamethasone 117pembrolizumab 106Doxorubicin 103Bevacizumab 103Gemcitabine 102Rituximab 96Prednisone 87Fluorouracil 86Pemetrexed 82Radiotherapy 77Vincristine 71Etoposide 71Capecitabine 69Nivolumab 68Trastuzumab 67Leucovorin 64Cytarabine 57Methotrexate 52Oxaliplatin 49atezolizumab 48Lenalidomide 43Ipilimumab 40Filgrastim 40Bortezomib 39Sorafenib 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Has results × Etanercept × Clear all
NCT00421174 2021-11-01

BMTCTN0403

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
37 enrolled 20 charts

Pneumonia

NCT01241591 2018-12-26

A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Pfizer

Phase 3 Completed
1,101 enrolled 46 charts
Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Pruritus, Psoriasis, Plaque, Amyloid

NCT01313221 2017-03-15

REFINE

Amgen

Phase 3 Completed
310 enrolled 32 charts
Lymphoid

Lymphoma, Follicular, Psoriasis

NCT00357903 2017-02-09

Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trials

Amgen

Phase 3 Completed
639 enrolled 27 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡